NSE: QUICKHEAL · BSE: 539678
QUICK HEAL TECH LTD
A cybersecurity software company with two segments — consumer and enterprise. Q1 FY27 revenue fell 21.4% YoY to ₹45 Cr, with consumer revenue down 39% and enterprise down 5.5%. Revenue is largely subscription-based, evidenced by deferred revenue of ₹52.3 Cr and an order book of ₹56 Cr as of Q1 FY27. Employee costs are the dominant expense at 70.1% of FY26 revenue, consistent with a software and services-led model. Receivables collection is improving, with overdues reduced from ₹151 Cr to ₹107 Cr. Harish Kumar GS took charge as CEO on June 18, 2026. AR · MarketPing reader · 2026-08-03
Revenue streams, as the annual report describes them. Consumer, Enterprise. Subscription-driven cybersecurity software business; labour-heavy, software/services-led model
Exhibit 1: Financial summary, FY22–FY26 (all audited; no estimate years)
| ₹ crore · consolidated | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|
| Revenue | 342 | 278 | 292 | 280 | 261 |
| EBITDA (ex other income) | 107 | 2 | 18 | (7) | (29) |
| margin % | 31.3 | 0.7 | 6.0 | (2.4) | (11.3) |
| Owners' profit | 0 | 0 | 0 | 0 | 0 |
| EPS, as reported (₹) | 14.01 | 1.14 | 4.56 | 0.94 | (1.98) |
| ROE % · ROCE % | 13.3 · 17.3 | 1.5 · 1.9 | 5.5 · 6.0 | 1.1 · 0.3 | (2.5) · (4.7) |
| Debt / equity (x) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash from operations | 127 | 31 | 18 | (22) | 15 |
| Capex | (6) | (4) | (8) | (14) | (15) |
Exhibit 2: Quarterly performance, last 8 quarters
| ₹ crore | Q2 FY25 | Q3 FY25 | Q4 FY25 | Q1 FY26 | Q2 FY26 | Q3 FY26 | Q4 FY26 | Q1 FY27 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 73 | 71 | 65 | 57 | 84 | 72 | 49 | 45 |
| Profit before tax | 5 | (2) | (7) | (7) | 10 | 6 | (30) | (7) |
| Net profit | 4 | 0 | (3) | (6) | 8 | 7 | (20) | (5) |
| EPS (₹) | 0.77 | 0.02 | (0.60) | (1.00) | 1.43 | 1.19 | (3.58) | (0.94) |
Exhibit 3: Filings of the last 90 days, with the measured price reaction
| Date · filing | Category | Importance | Next day % | 5-day % |
|---|---|---|---|---|
| 27 Oct 2026 · Quick Heal appoints internal auditor, company secretary and nodal officer | management changes | medium | — | — |
| 27 Oct 2026 · Quick Heal appoints internal auditor, company secretary and nodal officer | management changes | medium | — | — |
| 27 Oct 2026 · Quick Heal appoints Shailesh Shinde as Company Secretary and KMP | management changes | medium | — | — |
| 27 Oct 2026 · Quick Heal Q2 revenue falls 22%, profit rebounds to Rs 5.8 crore | results | medium | — | — |
| 26 Oct 2026 · Company Secretary and KMP Sarang Deshpande resigns for personal reasons | management changes | medium | — | — |
| 26 Oct 2026 · Company Secretary Sarang Deshpande resigns effective October 23, 2026 | management changes | high | — | — |
| 22 Oct 2026 · Quick Heal earnings call on Oct 28 for Q2 and H1 FY27 | board shareholder meetings | low | — | — |
| 21 Oct 2026 · Board meeting on Oct 27 to consider Q2 and H1 FY26-27 results | results | low | — | — |
| 19 Oct 2026 · Quick Heal Company Secretary Sarang Deshpande resigns citing personal reasons | management changes | medium | — | — |
| 19 Oct 2026 · Quick Heal Company Secretary Sarang Deshpande Resigns | management changes | medium | — | — |
How to read this document
| Where a broker report shows | This document shows | Why |
|---|---|---|
| A rating (BUY / ADD / REDUCE / SELL) | A state: the latest filed quarter and the measured reactions | an event is a fact; a rating is an opinion that requires SEBI RA registration |
| A target price and upside | The current price and the multiples against the group | a target is a forecast; a multiple is a measurement |
| Estimate years marked E | More audited years; no estimates | MarketPing publishes no forecasts — your own model lives on the Models page |
Sources, method and disclosures
This document is a statistical summary of publicly filed information and market data, prepared by software from primary sources: SEBI results XBRL filed with BSE and NSE, LODR disclosures, shareholding patterns, exchange price data. It contains no research recommendation, no price target and no opinion on the merits of any security, and is not a research report within the meaning of the SEBI (Research Analysts) Regulations, 2014, Regulation 2(1)(w)(vii). Financial statements are as filed (consolidated where the company files consolidated results). Ratios are computed over filed lines. Where a figure is unavailable the table shows a dash rather than an estimate. The business brief is written by MarketPing's reader from the annual report and checked against it; no figure in a table was generated by a model. Nothing here constitutes investment advice, an offer or a solicitation; readers should consult a SEBI-registered adviser before acting. MarketPing is not a SEBI-registered intermediary.